Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Reyno

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancerD I Jodrell, L M Reyno, R Sridhara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisoneE J Small, M Meyer, M E Marshall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group studyW H Miller, L M Reyno, G R Loewen, et al.
Journal of the National Cancer Institute|April 21, 1993
Suramin, an active drug for prostate cancer: interim observations in a phase I trialM A Eisenberger, L M Reyno, D I Jodrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancerM A Eisenberger, V J Sinibaldi, L M Reyno, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancerD I Jodrell, L M Reyno, R Sridhara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisoneE J Small, M Meyer, M E Marshall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group studyW H Miller, L M Reyno, G R Loewen, et al.
Journal of the National Cancer Institute|April 21, 1993
Suramin, an active drug for prostate cancer: interim observations in a phase I trialM A Eisenberger, L M Reyno, D I Jodrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancerM A Eisenberger, V J Sinibaldi, L M Reyno, et al.
Pageof 2